IDH1 Inhibitor 9
IDH1 Inhibitor 9 (compound 11S) is a potent IDH1 inhibitor with IC50 values of 124.4, 95.7 nM for IDH1 R132H, IDH1 R132C, respectively. IDH1 Inhibitor 9 induces apoptosis and cell cycle arrest at the S phase. IDH1 Inhibitor 9 shows anti-tumor activity[1].
Product Specifications
CAS Number
[3037967-71-5]
UNSPSC
12352005
Target
Apoptosis; Isocitrate Dehydrogenase (IDH)
Type
Reference compound
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/idh1-inhibitor-9.html
Smiles
OC1=CC(OC)=C(C/C=C(C)/C)C=C1C2=NC(N3CCNCC3)=NC(C4=CC=C(O)C=C4)=C2
Molecular Formula
C26H30N4O3
Molecular Weight
446.54
References & Citations
[1]Xu T, et al. Discovery of novel natural-product-derived mutant isocitrate dehydrogenases 1 inhibitors: Structure-based virtual screening, biological evaluation and structure-activity relationship study. Eur J Med Chem. 2024 Jun 17;275:116610.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IDH1
More Discoveries
Explore Other Products
Browse additional items from our catalog
D1876-48M-FITC 100 µL
Dectin-1 (C-type lectin domain family 7 member A, Dendritic cell-associated C-type lectin 1, DC-associated C-type lectin 1, Beta-glucan receptor, C-type lectin superfamily member 12, CLEC7A, BGR, CLECSF12, DECTIN1, UNQ539/PRO1082) (FITC) discontinued
Sign In for Pricing
View Details 
129032-HRP 100 µL
LCN2 (Neutrophil Gelatinase-associated Lipocalin, NGAL, 25kD alpha-2-microglobulin-related Subunit of MMP-9, Lipocalin-2, Oncogene 24p3, Siderocalin LCN2, p25, HNL, NGAL) (HRP)
Sign In for Pricing
View Details